REXCLAV 625 (Amoxicillin & Potassium Clavulanate Tablets I.P.) - Anti-infective formulation packaging box | RexCure Pharma
Anti-infective
Schedule H Rx
Genuine RexCure Batch PackagingImage 1 of 1
Anti-Infectives & AntibacterialsFilm-coated TabletsSchedule H Rx

REXCLAV 625

Amoxicillin & Potassium Clavulanate Tablets I.P.

Potent broad-spectrum antibacterial formulation combining Amoxicillin with Clavulanic Acid to combat beta-lactamase resistant pathogens.

Strength

500 mg + 125 mg (625 mg)

Commercial Pack

10 × 10 Tablets

Indicative MRP

Rs. 205.00

Drug Class

Schedule H Rx

Active Chemical Composition

Each film-coated tablet contains:

  • Amoxicillin Trihydrate IP equivalent to Amoxicillin 500 mg
  • Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 125 mg
  • Excipients q.s.

Primary Clinical Indications

1

Lower respiratory tract infections (acute bronchitis, pneumonia)

2

Acute bacterial sinusitis & otitis media

3

Skin and soft tissue infections

4

Urinary tract infections

Therapeutic Pharmacology & Overview

REXCLAV 625 provides definitive empiric therapy for moderate-to-severe community-acquired infections. The Potassium Clavulanate addition acts as an irreversible suicide inhibitor of bacterial beta-lactamase enzymes, restoring Amoxicillin full antimicrobial potency.

Key Formulation Advantages

Dual-action formulation with superior beta-lactamase enzyme inhibition
Broad-spectrum bactericidal coverage for Gram-positive and Gram-negative organisms
High clinical cure rates across outpatient adult cohorts
Packaged in premium moisture-barrier Alu-Alu blister foil

Dosage & Administration

Standard Adult / Pediatric Regimen:

1 tablet twice daily with meals or strictly as directed by the physician.

Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.

Packaging & Storage Details

Commercial Presentation:

10 × 10 Alu-Alu Strip in box with Dual Action protection shield

Storage Monograph:

Store in a cool, dry place protected from moisture and direct light below 25°C

Market Authorization Holder:

RexCure Pharmaceuticals Pvt. Ltd.

Hyderabad, Telangana

Clinical Inquiry / Sample Request

Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.

Contact Medical Desk

Drug Law Compliance

Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.
Segment Portfolio

Related Formulations in Anti-Infectives & Antibacterials

View Area (All) →
REXCLAV 457 DS (Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)) - Anti-infective formulation packaging by RexCure Pharma
Dry Syrup with Sterile Water

REXCLAV 457 DS

Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)

View Product Profile
REXCLAV 228.5 (Amoxicillin & Potassium Clavulanate Oral Suspension IP) - Anti-infective formulation packaging by RexCure Pharma
Dry Syrup with Sterile Water

REXCLAV 228.5

Amoxicillin & Potassium Clavulanate Oral Suspension IP

View Product Profile